Group | Immunized recombinant plasmid | Dose | Challenge isolate | Challenge dose (TCID50/ml) |
---|---|---|---|---|
pV/PCV2b | pVAX1 | 400 μg/ml | PCV2b | 2 × 105.5 |
pV/PCV2d | pVAX1 | 400 μg/ml | PCV2d | 2 × 105.5 |
pVO/PCV2b | pVAX1-ORF2 | 400 μg/ml | PCV2b | 2 × 105.5 |
pVO/PCV2d | pVAX1-ORF2 | 400 μg/ml | PCV2d | 2 × 105.5 |
pVOC3/PCV2b | pVAX1-ORF2-C3d-P28.3 | 400 μg/ml | PCV2b | 2 × 105.5 |
pVOC3/PCV2d | pVAX1-ORF2-C3d-P28.3 | 400 μg/ml | PCV2d | 2 × 105.5 |
Negative group | PBS | 1 ml | / | / |